Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Two Doses Outperformed Traditional Depression Therapies

Five years after receiving just two doses of psilocybin combined with psychotherapy, an remarkable 67% of patients with clinical depression remain completely symptom-free, according to groundbreaking follow-up research from Ohio State University. The study tracked participants from a 2021 clinical trial that found psilocybin-assisted therapy effective for treating major depressive disorder, and the long-term results have exceeded researchers’ most optimistic expectations. Lead author Professor Alan Davis noted that not only did the percentage of patients in complete remission actually increase from 58% at one year to 67% at five years, but participants also showed continued improvement across anxiety, global functioning, and overall wellbeing measures.

What makes these results even more extraordinary is that patients who previously lived with debilitating depression that interfered with their capacity to engage in life now describe their condition as “more situational and manageable.” Participants consistently ranked the psilocybin therapy among the most profound and meaningful experiences of their lives, comparing it to religious conversions or the birth of children. Even when researchers assumed the worst-case scenario for participants who didn’t complete the follow-up study, the treatment still showed significant and lasting depression reduction. The study offers hope that this innovative therapy could provide durable relief for people suffering from treatment-resistant depression, with many participants reporting they gained a greater capacity for positive emotions and enthusiasm that persisted regardless of whether any depression symptoms returned.

PrevPreviousThe “Extinct” Sea Creature That Just Returned
NextAboriginal Elders’ Ancient Fire MiracleNext

Recent Articles

Happy News

For The First Time In History Medicare Is Covering Weight Loss Drugs And The Price Is $50 A Month

May 14, 2026

Starting July 1, 2026 eligible Medicare enrollees will be able to access GLP-1 weight loss medications including Wegovy, Zepbound, and the newer drug Foundayo for a flat $50 monthly copay, in a historic first for the program, which has never before covered anti-obesity medications despite covering many of the serious

Read More
Happy News

Swedish Scientists Just Grew The Cells Type 1 Diabetes Destroys From Scratch

May 13, 2026

Scientists at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed a more reliable method for growing insulin-producing cells from human stem cells, and the results published in Stem Cell Reports represent one of the most encouraging steps yet toward a potential treatment for type 1 diabetes.

Read More
Happy News

New Research Reveals The Personality Trait That Predicts Whether You Will Seek Out A Cat When Stressed

May 12, 2026

A study published in the journal Anthrozoös, conducted by researchers at Washington State University and KU Leuven in Belgium, has identified the personality trait most likely to predict whether someone will seek out a cat for stress relief rather than a dog, and the answer has a name: emotionality. Researchers

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.